SCHEMBL3160894

SCHEMBL3160894

CC(C)C[C@H](N)C(=O)NCC(C)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 1/20 0.47
▸ ANPEP P15144 6/20 0.43
▸ RNPEP Q9H4A4 2/20 0.43
▸ DNPEP Q9ULA0 2/20 0.43
▸ LARS1 Q9P2J5 3/20 0.41
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ AAK1 Q2M2I8 1/20 0.39
▸ SLC1A3 P43003 1/20 0.37
▸ SLC1A2 P43004 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ LAP3 P28838 2/20 0.36
▸ ERAP1 Q9NZ08 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ GPR88 Q9GZN0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13789959 0.88 SLC7A5 (0.54) SLC7A5ANPEPRNPEPDNPEPLARS1
Hydrochloric Acid SCHEMBL8624053 0.86 SLC7A5 (0.52) SLC7A5ANPEPRNPEPDNPEPLARS1
Hydrochloric Acid SCHEMBL8624056 0.86 SLC7A5 (0.52) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL836923 0.79 SLC7A5 (0.45) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL830163 0.79 SLC7A5 (0.45) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL4015379 0.79 SLC7A5 (0.42) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL4007897 0.79 SLC7A5 (0.42) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL4014952 0.79 SLC7A5 (0.42) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL14528845 0.78 SLC7A5 (0.44) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL10783793 0.78 ANPEP (0.51) SLC7A5ANPEPRNPEPDNPEPLARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386908-B1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE INST PHARM & TOXICOLOGY AMMS (CN) 2010-03-03 — — EP claimed
US-7560473-B2 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES, P.L.A. (CN) 2009-07-14 — — US claimed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 — — CN claimed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 — — US claimed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 — — EP claimed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 — — CN claimed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 — — CN claimed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 — — CN claimed
EP-1386908-B1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE INST PHARM & TOXICOLOGY AMMS (CN) 2010-03-03 — — EP disclosed
US-7560473-B2 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES, P.L.A. (CN) 2009-07-14 — — US disclosed
CN-1250518-C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 — — CN disclosed
CN-1250519-C Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 — — CN disclosed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 — — CN disclosed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 — — US disclosed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 — — EP disclosed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 — — CN disclosed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 — — CN disclosed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use KCNMA1, KCNA5, KCNA1 SLC7A5 1775/4885ANPEP 4540/4885RNPEP 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback